Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).
about
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysisThe value of current diagnostic tests in prostate cancer screening.The story of the European Randomized Study of Screening for Prostate Cancer.Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant?Is screening for prostate cancer with prostate specific antigen an appropriate public health measure?Serendipity in detecting disease in low prostate-specific antigen ranges.Lead time associated with screening for prostate cancer.Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models.Screening without evidence of efficacy.The Finnish trial of prostate cancer screening: where are we now?Prostate atypia: clinical and pathological variables associated with cancer diagnosis on repeat biopsy.Is there an optimal prostate-specific antigen threshold for prostate biopsy?Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis.Do additional cores from cancer-suspicious lesions on transrectal ultrasound improve prostate cancer detection including index tumors over 12-core systematic biopsy?
P2860
Q24625223-93012A74-AC58-40BF-BE0B-67B8E73E0DF6Q34394012-BDBE8BD7-4CD2-46DE-ADF0-6025D0115AE5Q35675436-5DAC10E2-FFE6-40B6-AB83-19EE7004DCFBQ36018610-B0E77201-2E8C-4AEC-8B0F-510A5B0BCC5FQ36217132-61FBF9FF-A986-4DDC-A4D7-8C1482F5C21FQ39595302-9E4EAB61-CB40-4F3E-8099-EE14594CD3AEQ39669271-8E24C006-B77B-42D8-953B-8C9F4756576FQ39677104-BABE531E-F572-40A2-9E26-BDF7CE2A76FBQ39932994-A11BD25F-238A-445E-88D1-E88F28F315F7Q43155149-23A35265-A43D-4C9A-A54C-8FE3704EA812Q43484941-91E21B64-6D77-46AF-9D8F-AB06BA49F6C2Q44399197-B713E094-F495-4DBA-8569-87879E468065Q52892989-A9AA2D44-BA7F-4F6A-B917-1959EEDFE630Q53801746-ACFFF0A7-29AB-470D-8A55-61B51E2C4A51Q55313673-A69B55DF-D10B-41B1-BB2E-62E535E89A47
P2860
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region).
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Predictors for biopsy outcome ...... ate Cancer (Rotterdam region).
@en
Predictors for biopsy outcome ...... Screening for Prostate Cancer
@nl
type
label
Predictors for biopsy outcome ...... ate Cancer (Rotterdam region).
@en
Predictors for biopsy outcome ...... Screening for Prostate Cancer
@nl
prefLabel
Predictors for biopsy outcome ...... ate Cancer (Rotterdam region).
@en
Predictors for biopsy outcome ...... Screening for Prostate Cancer
@nl
P2093
P2860
P1433
P1476
Predictors for biopsy outcome ...... ate Cancer (Rotterdam region).
@en
P2093
Beemsterboer P
Hugosson J
Rietbergen J
Schröder FH
P2860
P304
P356
10.1002/(SICI)1097-0045(19990601)39:4<316::AID-PROS14>3.0.CO;2-O
P577
1999-06-01T00:00:00Z